Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose

Medical Physics

Volumn 30, Issue 1, 2003, Pages 34-40

  Wang, Jian Z ^a   Li, X Allen ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Brachytherapy; Equivalent uniform dose; External beam radiotherapy; Prostate cancer

Indexed keywords

DISEASES; ONCOLOGY; TRANSMISSION CONTROL PROTOCOL; TUMORS; UROLOGY;

BRACHYTHERAPY; EQUIVALENT UNIFORM DOSE; EXTERNAL BEAM RADIOTHERAPY; LINEAR-QUADRATIC MODELS; LOCALIZED PROSTATE CANCER; PROSTATE CANCERS; TREATMENT OUTCOMES; TUMOR CONTROL PROBABILITY;

RADIOTHERAPY;

IODINE 125; PALLADIUM 103;

ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; DOSE CALCULATION; EXTERNAL BEAM RADIOTHERAPY; MALE GENITAL TRACT CANCER; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; RADIATION DOSE;

EID: 0037240482     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1527674     Document Type: Article

References (30)

1. A. Pollack and G. K. Zagars, "External beam radiotherapy dose response of prostate cancer," Int. J. Radiat. Oncol., Biol., Phys, 39, 1011-1018 (1997).
2. A. Pollack, G. K. Zagars, L. G. Smith, J. A. Antolak, and I. I. Rosen, "Preliminary results of a randomized dose-escalation study comparing 70 Gy to 78 Gy for the treatment of prostate cancer (Abstr.)," Int. J. Radiat. Oncol., Biol., Phys. 45(Suppl 3), 146-147 (1999).
3. M. J. Zelefsky, S. A. Leibel, P. B. Gaudin, G. J. Kutcher, N. E. Fleshner, E. S. Venkatramen, V. E. Reuter, W. R. Fair, C. C. Ling, and Z. Fuks, "Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer," Int. J. Radiat. Oncol., Biol., Phys. 41, 491-500 (1998).
4. G. E. Hanks, A. L. Hanlon, W. H. Pinover, E. M. Horwitz, R. A. Price, and T. Schultheiss, "Dose selection for prostate cancer patients based on dose comparison and dose response studies," Int. J. Radiat. Oncol., Biol., Phys. 46, 823-832 (2000).
5. R. Valicenti, J. Lu, M. Pilepich, S. Asbell, and D. Grignon, "Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials," J. Clin. Oncol. 18, 2740-2746 (2000).
6. S. Levegrun, A. Jackson, M. J. Zelefsky, M. W. Skwarchuk, E. S. Venkatraman, W. Schlegel, Z. Fuks, S. A. Leibel, and C. C. Ling, "Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer, pitfalls in deducing radiobiologic parameters for tumors from clinical data," Int. J. Radiat. Oncol., Biol., Phys. 51, 1064-1080 (2001).
7. X. A. Li, J. Z. Wang, R. D. Stewart, and S. J. DiBiase, "Dose Escalation in Permanent Brachytherapy for Prostate Cancer: Dosimetric and Biological Considerations," Int. J. Radiat. Oncol. Biol. Phys. (submitted) (2002).
8. S. Nag, "Brachytherapy for prostate cancer: summary of American Brachytherapy Society recommendations," Semin Urol. Oncol. 18, 133-136 (2000).
9. M. J. Curran, G. A. Healey, W. Bihrle III, N. Goodman, and R. A. Roth, "Treatment of high-grade low-stage prostate cancer by high-dose-rate brachytherapy, " J. Endourol. 14, 351-356 (2000).
10. A. A. Martinez, G. Gustafson, J. Gonzalez, E. Armour, C. Mitchell, G. Edmundson, W. Spencer, J. Stromberg, R. Huang, and F. Vicini, "Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer," Int. J. Radiat. Oncol., Biol., Phys. 53, 316-327 (2002).
11. D. J. Brenner and E. J. Hall. "Fractionation and protraction for radio-therapy of prostate carcinoma," Int. J. Radiat. Oncol., Biol., Phys. 43, 1095-1101 (1999).
12. 125I prostate implants," Int. J. Radiat. Oncol., Biol., Phys. 41, 101-108 (1998).
13. G. E. Hanks, T. E. Schultheiss, A. L. Hanlon, M. Hunt, W. R. Lee, B. E. Epstein, and L. R. Coia, "Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study," Int. J. Radiat. Oncol., Biol., Phys. 37, 543-550 (1997).
14. J. Fowler, R. Chappell, and M. Ritter, "Is α/β for prostate cancer really low?," Int. J. Radiat. Oncol., Biol., Phys. 50, 1021-1031 (2001).
15. D. J. Brenner, A. A. Martinez, G. K. Edmundson, C. Mitchell, H. D. Thames, and E. P. Armour, "Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue," Int. J. Radiat. Oncol., Biol., Phys. 52, 6-13 (2002).
16. J. Z. Wang, M. Guerrero, and X. A. Li, "How low is the α/β ratio for prostate cancer?" Int. J. Radiat. Oncol. Biol. Phys. 55, (in press) (2003).
17. A. Niemierko, "Reporting and analyzing dose distribution: A concept of equivalent uniform dose," Med. Phys. 24, 103-110 (1997).
18. R. D. Zwicker, D. W. Arthur, B. D. Kavanagh, R. Mohan, and R. K. Schmidt-Ullrich, "Optimization of planar high-dose-rate implants," Int. J. Radiat. Oncol., Biol., Phys. 44, 1171-1177 (1999).
19. Q. Wu, R. Mohan, A. Niemierko, and R. Schmidt-Ullrich, "Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose," Int. J. Radiat. Oncol., Biol., Phys. 52, 224-235 (2002).
20. D. E. Lea and D. G. Catcheside, "The mechanism of the induction by radiation of chromosome aberrations in Tradescantia," J. Genet. 44, 216-245 (1942).
21. A. M. Kellerer and H. H. Rossi, "The theory of dual radiation action," Curr. Top. Radiat. Res. 8, 85-158 (1972).
22. R. G. Dale, "The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy," Br. J. Radiol. 58, 515-528 (1985).
23. R. G. Dale, "Radiobiological assessment of permanent implants using tumor repopulation factors in linear-quadratic model," Br. J. Radiol. 62, 241-244 (1989).
24. H. D. Thames, "An incomplete-repair mode for survival after fractionated and continuous irradiations," Int. J. Radiat. Biol. 47, 319-339 (1985).
25. D. J. Brenner and E. J. Hall, "Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy," Int. J. Radiat. Oncol., Biol., Phys. 20, 181-190 (1991).
26. R. K. Sachs, P. Hahnfeld, and D. J. Brenner, "Review: The link between low-LET dose-response relations and the underlying kinetics of damage production/repair/misrepair," Int. J. Radiat. Biol. 72, 351-374 (1997).
27. 125I seeds," Int. J. Radiat. Oncol., Biol., Phys. 28, 971-978 (1994).
28. C. R. King, T. A. DiPetrillo, and D. E. Wazer, "Optimal radiotherapy for prostate cancer: Predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models," Int. J. Radiat. Oncol., Biol., Phys. 46, 165-172 (2000).
29. 125I prostate implant? A dose response analysis of long-term urinary symptoms, biochemical control and post-treatment biopsy," Int. J. Radiat. Oncol., Biol., Phys. 48 (Suppl), 148-149 (2000).
30. K. Haustermans and J. F. Fowler, "A comment on proliferation rates in human prostate cancer [letter to editor]," Int. J. Radiat. Oncol., Biol., Phys. 48, 303 (2000).